Comprehensive Clinical Research

Berlin, New Jersey 08009

0 studies enrolling now · 60 studies all time

What they study most

Acne Vulgaris, Alzheimer Disease, Alzheimer's Disease, Arthritis, Atopic Dermatitis, Atrial Fibrillation, Atrial Flutter, Central Nervous System Diseases, Chronic Hepatitis C, Chronic Low Back Pain, Chronic Noncancer Pain, Chronic Nonmalignant and Nonneuropathic Pain

Studies at this site

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease — Completed
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain — Completed
VPD-737 for Treatment of Chronic Pruritus — Completed
Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units — Stopped early
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis — Completed
Tanezumab In Osteoarthritis Of The Hip Or Knee — Stopped early
Tanezumab In Osteoarthritis Of The Knee (2) — Completed
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects — Completed
Extension Study Of Tanezumab In Osteoarthritis — Stopped early
Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
Tanezumab in Osteoarthritis of the Knee — Completed
Tanezumab in Osteoarthritis Of The Hip — Completed
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder — Completed
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
ELND005 in Patients With Mild to Moderate Alzheimer's Disease — Completed
Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence — Completed
Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) — Completed
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis — Completed
Gilead Sustained Virologic Response (SVR) Registry — Completed
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia — Completed
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder — Completed
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine — Completed
Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes — Completed
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee — Completed
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin — Completed
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis — Completed
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients — Completed
Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain — Completed
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Completed
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis — Completed
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne — Completed
Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION) — Completed
Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon — Completed
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection — Completed
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects — Completed
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease — Completed